Publication: Dengue: A continuing global threat
2
Issued Date
2010-01-01
Resource Type
ISSN
17401534
17401526
17401526
Other identifier(s)
2-s2.0-79955602230
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Nature Reviews Microbiology. Vol.8, No.12 (2010), S7-S16
Suggested Citation
Maria G. Guzman, Scott B. Halstead, Harvey Artsob, Philippe Buchy, Jeremy Farrar, Duane J. Gubler, Elizabeth Hunsperger, Axel Kroeger, Harold S. Margolis, Eric Martí-nez, Michael B. Nathan, Jose Luis Pelegrino, Cameron Simmons, Sutee Yoksan, Rosanna W. Peeling Dengue: A continuing global threat. Nature Reviews Microbiology. Vol.8, No.12 (2010), S7-S16. doi:10.1038/nrmicro2460 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/29292
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Dengue: A continuing global threat
Other Contributor(s)
Instituto de Medicina Tropical Pedro Kouri
Pediatric Dengue Vaccine Initiative
National Microbiology Laboratory
Institut Pasteur du Cambodge
UCL
Duke-NUS Graduate Medical School Singapore
Centers for Disease Control and Prevention San Juan
Organisation Mondiale de la Sante
Mahidol University
London School of Hygiene & Tropical Medicine
Pediatric Dengue Vaccine Initiative
National Microbiology Laboratory
Institut Pasteur du Cambodge
UCL
Duke-NUS Graduate Medical School Singapore
Centers for Disease Control and Prevention San Juan
Organisation Mondiale de la Sante
Mahidol University
London School of Hygiene & Tropical Medicine
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ~50 million dengue infections and ~500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future. © 2010 Macmillan Publishers Limited. All rights reserved.